HeartBeam (NASDAQ:BEAT) saw shares surge over 70% today as it received a patent for an ECG patch monitor. The device is capable of detecting acute coronary syndrome such as myocardial infarction and angina, along with cardiac arrhythmia.
The company already has other patents for its technology that allows it to monitor and detect cardiac disease outside of healthcare facilities remotely.
